The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #8482 · Form 4 · 0001560152-25-000004

COLLEGIUM PHARMACEUTICAL, INC · Exercise / conversion · Common Stock

COLLEGIUM PHARMACEUTICAL, INC · Transacted November 12, 2025 · Filed November 14, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC records an exercise / conversion involving Common Stock on November 12, 2025. The reported quantity was 15,000. The filing date is November 14, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001267565
Security type
Non-derivative
Acquisition type
Exercise / conversion · Code M
Quantity acquired
15,000
Reported price
16.49
Reference value
247,350
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
79,634
Ownership description
Not reported
SEC acceptance time
Nov 14, 2025, 4:10 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

COLL · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2
The option is fully vested and exercisable.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.